Research advances in reprogramming somatic cells into stem cells and functional cells

HE Caimei; LIAO Zhuo'er; HE Zuping

PDF(2489 KB)

Journal of Hunan Normal University(Medical Science) ›› 2024, Vol. 21 ›› Issue (3) : 1-6.

Invited Review

Research advances in reprogramming somatic cells into stem cells and functional cells

HE Caimei, LIAO Zhuo'er, HE Zuping

Author information +

History +

Abstract

Somatic cells could be reprogrammed into stem cells and functional cells. As an example, Sertoli cells can be reprogrammed into pluripotent stem cells and germline stem cells, and thus they have significant applications in both regenerative and reproductive medicine. Overexpression of specific genes initiates a regenerative process of cells, which provides novel approaches for reprogramming human somatic cells into stem cells and other cells. Somatic cells reprogramming controls the stemness maintenance of stem cells and fate determinations of these cells. In this review, we discuss the recent advances in reprogramming somatic cells into various kinds of stem cells and functional cells. We also address the applications in of stem cells and functional cells derived from somatic cells in translational medicine.

Key words

somatic cells / reprogramming / stem cells / translational applications

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

HE Caimei, LIAO Zhuo'er, HE Zuping. Research advances in reprogramming somatic cells into stem cells and functional cells[J]. Journal of Hunan Normal University(Medical Science). 2024, 21(3): 1-6

References

[1] GURDON J B.The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles[J]. J Embryol Exp Morphol, 1962, 10: 622-640.
[2] CAMPBELL K H, MCWHIR J, RITCHIE W A, et al.Sheep cloned by nuclear transfer from a cultured cell line[J]. Nature, 1996, 380(6569): 64-66.
[3] WASHBURN R L, HIBLER T, THOMPSON L A, et al.Therapeutic application of Sertoli cells for treatment of various diseases[J]. Semin Cell Dev Biol, 2022, 121: 10-23.
[4] ZHANG W, CHEN W, CUI Y, et al.Direct reprogramming of human Sertoli cells into male germline stem cells with the self-renewal and differentiation potentials via overexpressing DAZL/DAZ2/BOULE genes[J]. Stem Cell Reports, 2021, 16(11): 2798-2812.
[5] KEE K, ANGELES V T, FLORES M, et al.Human DAZL, DAZ and BOULE genes modulate primordial germ-cell and haploid gamete formation[J]. Nature, 2009, 462(7270): 222-225.
[6] CORDERO P, GUERRERO-MONCAYO A, DE LOS REYES M, et al. Overexpression of DAZL, STRA8, and BOULE genes and treatment with BMP4 or retinoic acid modulate the expression of MSC overexpressing germ cell genes[J]. Front Vet Sci, 2021, 8: 667547.
[7] GUAN J, WANG G, WANG J, et al.Chemical reprogramming of human somatic cells to pluripotent stem cells[J]. Nature, 2022, 605(7909): 325-331.
[8] CORPUZ-HILSABECK M, CULTY M.Impact of endocrine disrupting chemicals and pharmaceuticals on Sertoli cell development and functions[J]. Front Endocrinol (Lausanne), 2023, 14: 1095894.
[9] PAREKH P A, GARCIA T X, HOFMANN M C.Regulation of GDNF expression in Sertoli cells[J]. Reproduction, 2019, 157(3): R95-R107.
[10] HAI Y, HOU J, LIU Y, et al.The roles and regulation of Sertoli cells in fate determinations of spermatogonial stem cells and spermatogenesis[J]. Semin Cell Dev Biol, 2014, 29: 66-75.
[11] ZHANG L, CHEN M, WEN Q, et al.Reprogramming of Sertoli cells to fetal-like Leydig cells by Wt1 ablation[J]. Proc Natl Acad Sci U S A, 2015, 112(13): 4003-4008.
[12] SHENG C, ZHENG Q, WU J, et al.Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors[J]. Cell Res, 2012, 22(1): 208-218.
[13] BUGANIM Y, ITSKOVICH E, HU Y C, et al.Direct reprogramming of fibroblasts into embryonic Sertoli-like cells by defined factors[J]. Cell Stem Cell, 2012, 11(3): 373-386.
[14] YANG Y, LI Q, HUANG R, et al.Small-Molecule-Driven Direct Reprogramming of Fibroblasts into Functional Sertoli-Like Cells as a Model for Male Reproductive Toxicology[J]. Adv Biol (Weinh), 2022, 6(5): e2101184.
[15] TOGO S, SATO T, SUGIURA H, et al.Differentiation of embryonic stem cells into fibroblast-like cells in three-dimensional type I collagen gel cultures[J]. In Vitro Cell Dev Biol Anim, 2011, 47(2): 114-124.
[16] LEMOS D R, DUFFIELD J S. Tissue-resident mesenchymal stromal cells: Implications for tissue-specific antifibrotic therapies [J]. Sci Transl Med, 2018, 10(426): eaan5174.
[17] CHOI Y H, KURTZ A, STAMM C.Mesenchymal stem cells for cardiac cell therapy[J]. Hum Gene Ther, 2011, 22(1): 3-17.
[18] MALIK N, RAO M S.A review of the methods for human iPSC derivation[J]. Methods Mol Biol, 2013, 997: 23-33.
[19] MC M J.Rudolf Virchow in 1858[J]. Lab Invest, 1958, 7(6): 549-553.
[20] HOLLWY R W, KIERNAN J A.Control of the initiation of DNA synthesis in 3T3 cells: serum factors[J]. Proc Natl Acad Sci U S A, 1974, 71(7): 2908-2911.
[21] ILIA K, SHAKIBA N, BINGHAM T, et al. Synthetic genetic circuits to uncover the OCT4 trajectories of successful reprogramming of human fibroblasts [J]. Sci Adv, 2023, 9(48): eadg8495.
[22] ZHOU Y, LIU Z, WELCH J D, et al. Single-cell transcriptomic analyses of cell fate transitions during human cardiac reprogramming [J]. Cell Stem Cell, 2019, 25(1): 149-164. e9.
[23] XIAO D, LIU X, ZHANG M, et al.Direct reprogramming of fibroblasts into neural stem cells by single non-neural progenitor transcription factor Ptf1a[J]. Nat Commun, 2018, 9(1): 2865.
[24] RING K L, TONG L M, BALESTRA M E, et al.Direct reprogramming of mouse and human fibroblasts into multipotent neural stem cells with a single factor[J]. Cell Stem Cell, 2012, 11(1): 100-109.
[25] VIERBUCHEN T, OSTERMEIER A, PANG Z P, et al.Direct conversion of fibroblasts to functional neurons by defined factors[J]. Nature, 2010, 463(7284): 1035-1041.
[26] PFISTERER U, KIRKEBY A, TORPER O, et al.Direct conversion of human fibroblasts to dopaminergic neurons[J]. Proc Natl Acad Sci U S A, 2011, 108(25): 10343-10348.
[27] TAKAHASHI K, YAMANAKA S.Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors[J]. Cell, 2006, 126(4): 663-676.
[28] EFE J A, HILCOVE S, KIM J, et al.Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy[J]. Nat Cell Biol, 2011, 13(3): 215-222.
[29] TANG Y, ARYAL S, GENG X, et al.TBX20 Improves Contractility and Mitochondrial Function During Direct Human Cardiac Reprogramming[J]. Circulation, 2022, 146(20): 1518-1536.
[30] SONG K, NAM Y J, LUO X, et al.Heart repair by reprogramming non-myocytes with cardiac transcription factors[J]. Nature, 2012, 485(7400): 599-604.
[31] FU J D, STONE N R, LIU L, et al.Direct reprogramming of human fibroblasts toward a cardiomyocyte-like state[J]. Stem Cell Reports, 2013, 1(3): 235-247.
[32] WADA R, MURAOKA N, INAGAWA K, et al.Induction of human cardiomyocyte-like cells from fibroblasts by defined factors[J]. Proc Natl Acad Sci U S A, 2013, 110(31): 12667-12672.
[33] TAO Y, YANG Y, YANG Z, et al.Robust small molecule-aided cardiac reprogramming systems selective to cardiac fibroblasts[J]. iScience, 2023, 26(12): 108466.
[34] ZHAO Y, LONDONO P, CAO Y, et al.High-efficiency reprogramming of fibroblasts into cardiomyocytes requires suppression of pro-fibrotic signalling[J]. Nat Commun, 2015, 6: 8243.
[35] GEBAUER B S, HRICIK D E, ATALLAH A, et al.Evolution of the enzyme-linked immunosorbent spot assay for post-transplant alloreactivity as a potentially useful immune monitoring tool[J]. Am J Transplant, 2002, 2(9): 857-866.
[36] AUTISSIER P, SOULAS C, BURDO T H, et al.Evaluation of a 12-color flow cytometry panel to study lymphocyte, monocyte, and dendritic cell subsets in humans[J]. Cytometry A, 2010, 77(5): 410-419.
[37] FUJISAKI H, KAKUDA H, IMAI C, et al.Replicative potential of human natural killer cells[J]. Br J Haematol, 2009, 145(5): 606-613.
[38] QAYED M, MCGUIRK J P, MYERS G D, et al.Leukapheresis guidance and best practices for optimal chimeric antigen receptor T-cell manufacturing[J]. Cytotherapy, 2022, 24(9): 869-878.
[39] SEKI T, YUASA S, FUKUDA K.Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus[J]. Nat Protoc, 2012, 7(4): 718-728.
[40] EMINLI S, FOUDI A, STADTFELD M, et al.Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells[J]. Nat Genet, 2009, 41(9): 968-976.
[41] SEKI T, YUASA S, ODA M, et al.Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells[J]. Cell Stem Cell, 2010, 7(1): 11-14.
[42] BRIGGS R, KING T J.Transplantation of Living Nuclei From Blastula Cells into Enucleated Frogs' Eggs[J]. Proc Natl Acad Sci U S A, 1952, 38(5): 455-463.
[43] GURDON J B.Adult frogs derived from the nuclei of single somatic cells[J]. Dev Biol, 1962, 4: 256-273.
[44] WILMUT I, SCHNIEKE A E, MCWHIR J, et al.Viable offspring derived from fetal and adult mammalian cells[J]. Nature, 1997, 385(6619): 810-813.
[45] INOUE K, KOHDA T, SUGIMOTO M, et al.Impeding Xist expression from the active X chromosome improves mouse somatic cell nuclear transfer[J]. Science, 2010, 330(6003): 496-499.
[46] MATOBA S, ZHANG Y.Somatic cell nuclear transfer reprogramming: mechanisms and applications[J]. Cell Stem Cell, 2018, 23(4): 471-485.
[47] LIU W, LIU X, WANG C, et al.Identification of key factors conquering developmental arrest of somatic cell cloned embryos by combining embryo biopsy and single-cell sequencing[J]. Cell Discov, 2016, 2: 16010.
[48] CHOI J, COSTA M L, MERMELSTEIN C S, et al.MyoD converts primary dermal fibroblasts, chondroblasts, smooth muscle, and retinal pigmented epithelial cells into striated mononucleated myoblasts and multinucleated myotubes[J]. Proc Natl Acad Sci U S A, 1990, 87(20): 7988-7992.
[49] CHEN J, LIU J, CHEN Y, et al.Rational optimization of reprogramming culture conditions for the generation of induced pluripotent stem cells with ultra-high efficiency and fast kinetics[J]. Cell Res, 2011, 21(6): 884-894.
[50] ZHOU Q, BROWN J, KANAREK A, et al.In vivo reprogramming of adult pancreatic exocrine cells to beta-cells[J]. Nature, 2008, 455(7213): 627-632.
[51] IEDA M, FU J D, DELGADO-OLGUIN P, et al.Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors[J]. Cell, 2010, 142(3): 375-386.
[52] YOO A S, SUN A X, LI L, et al.MicroRNA-mediated conversion of human fibroblasts to neurons[J]. Nature, 2011, 476(7359): 228-231.
[53] GOLDENSON B H, HOR P, KAUFMAN D S. iPSC-derived natural killer cell therapies - expansion and targeting[J]. Front Immunol, 2022, 13: 841107.
[54] KARAGIANNIS P, TAKAHASHI K, SAITO M, et al.Induced pluripotent stem cells and their use in human models of disease and development[J]. Physiol Rev, 2019, 99(1): 79-114.
[55] LI Y, ZHANG Q, YIN X, et al.Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules[J]. Cell Res, 2011, 21(1): 196-204.
[56] HOU P, LI Y, ZHANG X, et al.Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds[J]. Science, 2013, 341(6146): 651-654.
[57] ZHAO Y, ZHAO T, GUAN J, et al.A XEN-like state bridges somatic cells to pluripotency during chemical reprogramming[J]. Cell, 2015, 163(7): 1678-1691.
[58] LI X, ZUO X, JING J, et al.Small-molecule-driven direct reprogramming of mouse fibroblasts into functional neurons[J]. Cell Stem Cell, 2015, 17(2): 195-203.
[59] HU W, QIU B, GUAN W, et al.Direct Conversion of normal and Alzheimer's disease human fibroblasts into neuronal cells by small molecules[J]. Cell Stem Cell, 2015, 17(2): 204-212.
[60] XIE B, SUN D, DU Y, et al.A two-step lineage reprogramming strategy to generate functionally competent human hepatocytes from fibroblasts[J]. Cell Res, 2019, 29(9): 696-710.